The Journal of family practice
-
• Discontinuing statin therapy results in increased cardiovascular risk. • The nocebo effect is a common reason for perceived statin intolerance. • Statin intolerance is much less commonly reported in clinical trials than in clinical practice, suggesting that patient education and other safeguards employed in clinical trials are important to include in clinical practice. • Several strategies are available that can enable continuation of statin therapy in patients who are truly statin-intolerant.
-
► Seizures with postpartum onset ► Posttraumatic stress disorder ► History of depression.
-
Improving the timeliness and quality of your guidance on work disability lessens the impact of health problems on patients' lives and livelihoods.
-
In the American Southwest, a common problem can be diagnosed with the knowledge of the local environment and its inhabitants.
-
Case Reports Randomized Controlled Trial
Prescribe an SGLT2 inhibitor for heart failure in the absence of diabetes?
An RCT demonstrates that dapagliflozin produces better cardiovascular outcomes than placebo for heart failure patients with and without diabetes.